WellPoint Inc (WLP): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

WellPoint ( WLP) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.2%. By the end of trading, WellPoint rose $1.46 (1.7%) to $89.26 on average volume. Throughout the day, 2,009,119 shares of WellPoint exchanged hands as compared to its average daily volume of 1,891,900 shares. The stock ranged in a price between $87.79-$89.44 after having opened the day at $87.80 as compared to the previous trading day's close of $87.80. Other companies within the Health Care sector that increased today were: GW Pharmaceuticals PLC ADR ( GWPH), up 47.7%, Aoxing Pharmaceutical Company ( AXN), up 31.8%, Galectin Therapeutics ( GALT), up 26.6% and GTx ( GTXI), up 21.4%.

WellPoint, Inc., a health benefits company, through its subsidiaries, offers network-based managed care plans to large and small employer, individual, Medicaid, and senior markets in the United States. The company operates through three segments: Commercial, Consumer, and Other. WellPoint has a market cap of $25.9 billion and is part of the health services industry. Shares are up 44.1% year to date as of the close of trading on Tuesday. Currently there are 7 analysts that rate WellPoint a buy, 1 analyst rates it a sell, and 9 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, NanoString Technologies ( NSTG), down 15.4%, AVANIR Pharmaceuticals ( AVNR), down 13.4%, Idenix Pharmaceuticals ( IDIX), down 7.9% and ProPhase Labs ( PRPH), down 7.0% , were all laggards within the health care sector with Vertex Pharmaceuticals ( VRTX) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.